Newsroom

PALO ALTO, Calif.--(BUSINESS WIRE)--500 Global, una de las empresas de capital riesgo más activas de todo el mundo1, anunció el día de hoy el ascenso de Mei Chel Tan a socia directora global. Su nombramiento refleja tanto su liderazgo en la expansión de la presencia de 500 Global en regiones de alto crecimiento, como la acelerada transformación de la inteligencia artificial, que está posicionando a los mercados incipientes y emergentes como motores centrales de la próxima era de crecimiento glo...

LONDON--(BUSINESS WIRE)--  First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the monthly distribution for First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF (the “Fund”). ISIN Fund Name Frequency Dividend per Share IE000SNMGYT5 First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF Class B Monthly $0.1474 (USD) The Fund’s investment manager is First Trust Advisors L.P. (“FTA”). FTA has appointed Vest Financial LLC...

LONDON--(BUSINESS WIRE)--First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the monthly distribution for First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF (the “Fund”). ISIN Fund Name Frequency Dividend per Share IE000SNMGYT5 First Trust Vest S&P 500® Dividend Aristocrats Target Income UCITS ETF Class B Monthly $0.1474 (USD) The Fund’s investment manager is First Trust Advisors L.P. (“FTA”). FTA has appointed Vest Financial LLC t...

北卡羅來納州莫里斯維爾--(BUSINESS WIRE)--(美國商業資訊)-- 提供全方位服務的委託研究機構(CRO) WEP Clinical (WEP)宣布收購總部位於荷蘭、專注於為生物科技公司提供靈活、高品質臨床營運服務的歐洲CRO Siron Clinical (Siron)。本次收購將擴大WEP的全球業務版圖，強化其在複雜、罕見及專科治療領域提供端對端第一至第四期臨床試驗解決方案的能力。 Siron成立於2000年，總部位於荷蘭，在比利時和德國另設有辦事處，臨床研究專業人員遍布歐洲和中東地區。該公司主營臨床營運相關業務，包括專案管理、臨床監查、品質保證以及監管申報。Siron已支援展開超過120項研究，在罕見疾病、兒科研究和醫療器材臨床試驗領域擁有卓越的業績記錄。 WEP創辦人兼執行長Jaswinder Khera表示： 「本次收購是我們的CRO服務發展進程中的一個重要里程碑。透過整合WEP的全球基礎設施和Siron在複雜及小眾適應症領域的深厚營運專長，我們能夠為試驗委託者提供從早期開發到獲准後研究的順暢支援。雙方共同的企業文化、價值觀和對卓越執行的承諾，讓這次合作成為理想...

PITTSBURGH--(BUSINESS WIRE)--Skild AI, an AI robotics company building a scalable foundation model for robotics, today announced it has raised close to $1.4 billion in funding led by SoftBank Group, with participation from NVentures (NVIDIA’s venture capital arm), Macquarie Capital (entities administered by Macquarie Capital), Jeff Bezos (through Bezos Expeditions), Disruptive, and 1789 Capital. Lightspeed, Felicis, Coatue, and Sequoia Capital have doubled down on their investments. Several str...

LONDON--(BUSINESS WIRE)--  14-January-2026 Issue: Coventry Building Society, CB SERIES 17 XS2954939414 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 21-October-2025 Date To: 21-January-2026 Record Date: 20-January-2026 Value Date: 21-January-2026 Benchmark Rate: 3.928% Margin: 0.55% Total Rate: 4.478% Floor: 0% Number of Days: 92 Day Count: Actual / 365 (Fixed) Interest Frequency: Quarterly Denominatio...

北卡罗来纳州莫里斯维尔--(BUSINESS WIRE)--(美国商业资讯)-- 提供全方位服务的合同研究组织(CRO) WEP Clinical (WEP)宣布收购总部位于荷兰、专注于为生物技术公司提供灵活、高质量临床运营服务的欧洲CRO Siron Clinical (Siron)。本次收购将拓展WEP的全球业务版图，强化其在复杂、罕见及专科治疗领域提供端到端I–IV期临床试验解决方案的能力。 Siron成立于2000年，总部位于荷兰，在比利时和德国另设有办事处，临床研究专业人员遍布欧洲和中东地区。该公司主营临床运营相关业务，包括项目管理、临床监查、质量保证以及监管申报。Siron已支持开展超过120项研究，在罕见病、儿科研究和医疗器械临床试验领域拥有卓越的业绩记录。 WEP创始人兼首席执行官Jaswinder Khera表示： “本次收购是我们的CRO服务发展进程中的一个重要里程碑。通过整合WEP的全球基础设施和Siron在复杂及小众适应症领域的深厚运营专长，我们能够为申办方提供从早期开发到获批后研究的无缝支持。双方共同的企业文化、价值观和对卓越执行的承诺，让这次合作成为理想的战...

DUBLIN--(BUSINESS WIRE)--The "Negative Carbon Portland Cement Global Market Report 2025" has been added to ResearchAndMarkets.com's offering. The negative carbon Portland cement market has experienced significant growth recently, with its size projected to expand from $0.64 billion in 2024 to $0.79 billion in 2025, at a robust CAGR of 24.1%. This growth is attributed to the rising demand for sustainable building materials, a heightened awareness of reducing carbon footprints, and regulatory sup...

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage-backed certificates from Morgan Stanley Residential Mortgage Loan Trust 2026-NQM1 (MSRM 2026-NQM1). MSRM 2026-NQM1 is an RMBS transaction sponsored by Morgan Stanley Mortgage Capital Holdings LLC as seller/sponsor and includes a meaningful concentration of collateral that KBRA considers to be “non-prime.” The $397.6 million RMBS transaction is collateralized by a pool of 832 residential mortgages, with fixed-...

MORRISVILLE, Carolina do Norte--(BUSINESS WIRE)--A WEP Clinical (WEP), uma organização de pesquisa por contrato (CRO) de serviço completo, anuncia a aquisição da Siron Clinical (Siron), uma CRO europeia com sede na Holanda, especializada em operações clínicas flexíveis e de alta qualidade para empresas de biotecnologia. A aquisição amplia a presença global da WEP e fortalece sua capacidade de oferecer soluções completas de estudos clínicos de Fase I–IV em áreas terapêuticas complexas, raras e e...